Company intelligence / Profile preview

LXRepair

La Tronche / Grenoble area, Auvergne-Rhône-Alpes, Francegeneviatechnologies.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

LXRepair develops and provides diagnostic solutions that analyze the activity of DNA repair enzymes. Their technology helps clinicians optimize radiotherapy and chemotherapy by personalizing treatment based on individual tumor biology. The company’s approach aims to improve outcomes in oncology by identifying patients’ unique responses to cancer therapies.

Therapeutic areas: Oncology
Modalities: Diagnostic kitsDNA repair enzyme signature analysis
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on LXRepair.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LXRepair.

Explore the full profile